Sebastian Krug

16PUBLICATIONS
43CO-AUTHORS
Molecular targetsSurgeryCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jan 09, 2025
Activity and Safety of Avelumab in High-Grade Neuroendocrine Tumors and Poorly Differentiated Neuroendocrine Carcinomas Progressive after Chemotherapy (AveNEC Trial).

Christian Fottner, Leonidas Apostolidis, Sebastian Krug

|Dec 13, 2022
Postoperative Sigmoidoscopy and Biopsy After Elective Endovascular and Open Aortic Surgery for Preventing Mortality by Colonic Ischemia (PSB-Aorta-CI): Protocol for a Prospective Study.

Artur Rebelo, Ulrich Ronellenfitsch, Jumber Partsakhashvili

|Dec 11, 2022
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience.

Friedrich Sinner, Matthias Pinter, Bernhard Scheiner

|Jun 10, 2022
Updates on Diagnostic and Therapeutic Management of Gastrointestinal and Pancreatic NET.

Sebastian Krug, Jörg Schrader, Anja Rinke

|Feb 15, 2022
The Patient's Point of View: COVID-19 and Neuroendocrine Tumor Disease.

Sebastian Krug, Maryam Khosravian, Julia Weissbach

|Sep 10, 2021
Efficacy and Safety of Neoadjuvant Gemcitabine Plus Nab-Paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Cancer-A Systematic Review and Meta-Analysis.

Marko Damm, Ljupcho Efremov, Benedikt Birnbach

Pageof 3

Frequent Collaborators

8 joint publications

Patrick Michl

5 joint publications

Jonas Rosendahl

3 joint publications

Thomas Mathias Gress

2 joint publications

Jakob Garbe